Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18490651

J. Clin. Oncol. 2008 Jul 10 26 20 3317-23

Download in:

View as

Triples

General Info

PMID
18490651